Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | PDE2A | O00408 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | TDO2 | P48775 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | TOP2A | P11388 | 1/20 | 0.40 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30398975 | 1.00 | TP53 (0.63) | TP53LMNAHTTPDE2AMEN1 | |
| SCHEMBL13866426 | 1.00 | TP53 (0.63) | TP53LMNAHTTPDE2AMEN1 | |
| SCHEMBL14992635 | 1.00 | TP53 (0.63) | TP53LMNAHTTPDE2AMEN1 | |
| SCHEMBL30869925 | 1.00 | TP53 (0.63) | TP53LMNAHTTPDE2AMEN1 | |
| SCHEMBL253677 | 0.83 | TP53 (0.59) | TP53LMNAHTTPDE2AMEN1 | |
| SCHEMBL252437 | 0.83 | TP53 (0.59) | TP53LMNAHTTPDE2AMEN1 | |
| SCHEMBL29528234 | 0.83 | TP53 (0.59) | TP53LMNAHTTPDE2AMEN1 | |
| SCHEMBL29529206 | 0.83 | TP53 (0.59) | TP53LMNAHTTPDE2AMEN1 | |
| SCHEMBL29528410 | 0.83 | TP53 (0.59) | TP53LMNAHTTPDE2AMEN1 | |
| SCHEMBL247766 | 0.83 | TP53 (0.59) | TP53LMNAHTTPDE2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120009438-A | Detection method of novel disinfection byproducts in aquatic products | 舟山市食品药品检验检测研究院 | 2025-05-16 | — | — | CN | claimed |
| CN-109180418-B | Method for synthesizing pesticide intermediate 2, 4-dichloroacetophenone by recycling propylene oxide co-product materials | 江苏扬农化工集团有限公司 | 2021-03-30 | — | — | CN | claimed |
| CN-109180418-A | A kind of propylene oxide co-production object resource utilization synthetic pesticide intermediate 2,4 dichloro benzene ethyl ketone method | 江苏扬农化工集团有限公司 | 2019-01-11 | — | — | CN | claimed |
| CN-120192324-A | Heterocyclic compound, pharmaceutical composition and application | 上海医药集团股份有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-120009438-A | Detection method of novel disinfection byproducts in aquatic products | 舟山市食品药品检验检测研究院 | 2025-05-16 | — | — | CN | disclosed |
| WO-2025056065-A1 | CHEMOKINE RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION, AND USE | 上海医药集团股份有限公司 | 2025-03-20 | — | — | WO | disclosed |
| CN-119638669-A | Chemokine receptor antagonist, pharmaceutical composition and application | 上海医药集团股份有限公司 | 2025-03-18 | — | — | CN | disclosed |
| US-20240199620-A1 | CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF | RAPT THERAPEUTICS, INC. | 2024-06-20 | — | — | US | disclosed |
| CN-117777000-A | Synthesis method of (R) -1- (2, 4-dichlorophenyl) ethylamine and key intermediate | 苏州楚凯药业有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-109789146-B | Chemokine receptor modulators and uses thereof | 拉普特医疗公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115028586-A | Preparation method of chiral (S) -imazalil | 池州中瑞化工有限公司 | 2022-09-09 | — | — | CN | disclosed |
| US-5696299-A | Optical resolution for producing optically active alcohol | THE NISSHIN OIL MILLS, LTD. (JP) | 1997-12-09 | — | — | US | disclosed |
| EP-0531715-B1 | Process for producing alcohols and ketones | SUMITOMO CHEMICAL CO (JP) | 1997-11-05 | — | — | EP | disclosed |
| US-5600027-A | Process for producing optically active alcohol containing phenyl group | THE NISSHIN OIL MILLS, LTD. (JP) | 1997-02-04 | — | — | US | disclosed |
| EP-0714984-A2 | Process for producing optically active alcohol containing phenyl group | The Nisshin Oil Mills, Ltd. (JP) | 1996-06-05 | — | — | EP | disclosed |
| EP-0709465-A2 | Optical resolution for producing optically active alcohol | The Nisshin Oil Mills, Ltd. (JP) | 1996-05-01 | — | — | EP | disclosed |
| US-5426237-A | Oxidation of straight, branched or cyclic alkanes and benzene derivatives in presence of transition metal catalyst and aldehyde | SUMITOMO CHEMICAL CO., LTD. (JP) | 1995-06-20 | — | — | US | disclosed |
| EP-0531715-A1 | Process for producing alcohols and ketones | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-03-17 | — | — | EP | disclosed |
| EP-0258391-A1 | USE OF HETEROCYCLIC NITROGEN-CONTAINING COMPOUNDS FOR REDUCING MOISTURE LOSS FROM PLANTS AND INCREASING CROP YIELD | RHONE POULENC NEDERLAND B.V. (NL) | 1988-03-09 | — | — | EP | disclosed |
| WO-1987004321-A2 | USE OF HETEROCYCLIC NITROGEN-CONTAINING COMPOUNDS FOR REDUCING MOISTURE LOSS FROM PLANTS AND INCREASING CROP YIELD | RHONE-POULENC NEDERLANDS B.V. (NL) | 1987-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199620-A1 | CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF | CCR4, CCR1, CCR3 | TP53 3886/4885LMNA 4831/4885HTT 4810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.